Skip to Main Content

Advertisement

Skip Nav Destination

Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy

J Immunol (2024) 212 (2): 188–198.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal